{"transactions":[{"id":1459304,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-07-03T20:39:43.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":1843,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":71254,"source":{"system":"sec-edgar","filing":"0001601830-24-000097","document":"wk-form4_1720039177.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000097/wk-form4_1720039177.xml","form_type":"4"}},{"id":1489439,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-05T22:12:31.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":26193,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option will vest and become exercisable on the earlier of June 3, 2025 or the date of the Issuer's 2025 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":26193,"derivative":{"exercise_price":8.59,"expiration_date":"2034-06-03","underlying":"Class A Common Stock","underlying_shares":26193},"source":{"system":"sec-edgar","filing":"0001601830-24-000073","document":"wk-form4_1717625544.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000073/wk-form4_1717625544.xml","form_type":"4"}},{"id":1489438,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-06-05T22:12:31.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":13097,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units automatically granted pursuant to the Issuer's Outside Director Compensation Policy. The restricted stock units will vest on the earlier of June 3, 2025 or the day prior to the Issuer's 2025 annual meeting of stockholders, subject to Reporting Person's continued service to the Issuer."}],"balance_after":69411,"source":{"system":"sec-edgar","filing":"0001601830-24-000073","document":"wk-form4_1717625544.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000073/wk-form4_1717625544.xml","form_type":"4"}},{"id":1533814,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-29T20:10:23.000Z","date":"2024-04-26","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option vests in equal monthly installments each month following July 31, 2023 for the subsequent thirty-six months, subject to the Reporting Person's continued service with BEAM through each vesting date."}],"balance_after":25000,"derivative":{"exercise_price":30.87,"expiration_date":"2034-04-26","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000950170-24-049854","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017024049854/ownership.xml","form_type":"4"}},{"id":1533813,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-04-29T20:10:23.000Z","date":"2024-04-26","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted to the Reporting Person under the Beam Therapeutics Inc. (\"BEAM\") 2019 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of BEAM's common stock. The RSU vests in three substantially equal annual installments on each of the first three anniversaries of September 30, 2023, subject to the Reporting Person's continued service with BEAM through each vesting date."}],"balance_after":82637,"source":{"system":"sec-edgar","filing":"0000950170-24-049854","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017024049854/ownership.xml","form_type":"4"}},{"id":1549851,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-04-03T23:39:36.000Z","date":"2024-04-01","kind":"sale","planned":true,"acquired":false,"shares":5446,"price":32.12,"value":174925.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were automatically sold in a non-discretionary transaction by the Reporting Person in order to cover tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person under the Beam Therapeutics Inc. (\"BEAM\") 2019 Equity Incentive Plan on each of March 31, 2021, March 31, 2022 and March 31, 2023. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $32.10 to $32.18, inclusive. The Reporting Person undertakes to provide to BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":70137,"source":{"system":"sec-edgar","filing":"0000950170-24-041437","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017024041437/ownership.xml","form_type":"4"}},{"id":1548637,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-04-03T21:42:50.000Z","date":"2024-04-01","kind":"grant","planned":false,"acquired":true,"shares":1467,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were issued pursuant to Issuer's Outside Director Compensation Policy."}],"balance_after":56314,"source":{"system":"sec-edgar","filing":"0001601830-24-000028","document":"wk-form4_1712180559.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000028/wk-form4_1712180559.xml","form_type":"4"}},{"id":1553726,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-04-02T20:10:20.000Z","date":"2024-03-31","kind":"grant","planned":false,"acquired":true,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted to the Reporting Person under the Beam Therapeutics Inc. (\"BEAM\") 2019 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of BEAM's common stock. The RSUs vest in four substantially equal installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service with BEAM through each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 283 shares and 683 shares acquired by the Reporting Person under the BEAM Amended and Restated 2019 Employee Stock Purchase Plan on September 30, 2023 and March 31, 2024, respectively."}],"balance_after":75583,"source":{"system":"sec-edgar","filing":"0000950170-24-040154","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017024040154/ownership.xml","form_type":"4"}},{"id":1661855,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-02T21:05:26.000Z","date":"2024-01-31","kind":"grant","planned":false,"acquired":true,"shares":55000,"price":24.4,"value":1342000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests in equal monthly installments each month following the date of grant for the subsequent 48 months, subject to the Reporting Person's continued service with Beam Therapeutics Inc. through each vesting date."}],"balance_after":55000,"derivative":{"exercise_price":24.4,"expiration_date":"2034-01-31","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0000950170-24-010480","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017024010480/ownership.xml","form_type":"4"}},{"id":1829407,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2023-07-14T22:52:12.000Z","date":"2023-07-13","kind":"sale","planned":false,"acquired":false,"shares":8275,"price":12.5852,"value":104142.53,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales are pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $12.105 to $12.98 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request."}],"balance_after":54847,"source":{"system":"sec-edgar","filing":"0001209191-23-042305","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123042305/doc4.xml","form_type":"4"}},{"id":1829406,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2023-07-14T22:52:12.000Z","date":"2023-07-12","kind":"sale","planned":false,"acquired":false,"shares":3157,"price":14.0821,"value":44457.1897,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales are pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $13.81 to $14.56 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request."}],"balance_after":63122,"source":{"system":"sec-edgar","filing":"0001209191-23-042305","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123042305/doc4.xml","form_type":"4"}},{"id":1829405,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2023-07-14T22:52:12.000Z","date":"2023-07-12","kind":"sale","planned":false,"acquired":false,"shares":3195,"price":13.1845,"value":42124.4775,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales are pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $12.76 to $13.72 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request."}],"balance_after":66279,"source":{"system":"sec-edgar","filing":"0001209191-23-042305","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123042305/doc4.xml","form_type":"4"}},{"id":1829404,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2023-07-14T22:52:12.000Z","date":"2023-07-12","kind":"sale","planned":false,"acquired":false,"shares":78071,"price":12.1465,"value":948289.4015,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales are pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $11.60 to $12.54 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request."}],"balance_after":69474,"source":{"system":"sec-edgar","filing":"0001209191-23-042305","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123042305/doc4.xml","form_type":"4"}},{"id":1829403,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2023-07-14T22:52:12.000Z","date":"2023-07-12","kind":"sale","planned":false,"acquired":false,"shares":24302,"price":11.2501,"value":273399.9302,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales are pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sales price reported herein is a weighted average price.  These shares were sold in multiple lots at prices ranging from $10.60 to $11.59 per share.  Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request."}],"balance_after":147545,"source":{"system":"sec-edgar","filing":"0001209191-23-042305","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123042305/doc4.xml","form_type":"4"}},{"id":1847510,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-21T21:19:07.000Z","date":"2023-06-16","kind":"grant","planned":false,"acquired":true,"shares":25224,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The shares subject to this option will vest and become exercisable on the earlier of June 16, 2024 or the date of the Issuer's 2024 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":25224,"derivative":{"exercise_price":8.92,"exercise_date":"2024-06-16","expiration_date":"2033-06-16","underlying":"Class A Common Stock","underlying_shares":25224},"source":{"system":"sec-edgar","filing":"0001209191-23-038838","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123038838/doc4.xml","form_type":"4"}},{"id":1847509,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2023-06-21T21:19:07.000Z","date":"2023-06-16","kind":"grant","planned":false,"acquired":true,"shares":12612,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units automatically granted pursuant to the Issuer's Outside Director Compensation Policy.  The restricted stock units will vest on the earlier of June 16, 2024 or the day prior to the Issuer's 2024 annual meeting of stockholders, subject to Reporting Person's continued service to the Issuer."}],"balance_after":171847,"source":{"system":"sec-edgar","filing":"0001209191-23-038838","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123038838/doc4.xml","form_type":"4"}},{"id":1917257,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-19T20:30:45.000Z","date":"2023-01-31","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On March 31, 2023, the Reporting Person filed a Form 4 that reported the acquisition of a stock option.  The Form 4 inadvertently reported the number of stock options acquired (and the number of shares of common stock underlying such stock options) as 20,000 when, as reported in this amendment, the correct number is 40,000."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option vests in equal monthly installments each month following the date of grant for the subsequent 48 months, subject to the Reporting Person's continued service with Beam Therapeutics Inc. through each vesting date."}],"balance_after":40000,"derivative":{"exercise_price":43.45,"expiration_date":"2033-01-31","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0000950170-23-013483","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017023013483/ownership.xml","form_type":"4/A","original_submission_date":"2023-03-31"}},{"id":1925217,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-04-06T00:30:09.000Z","date":"2023-04-04","kind":"sale","planned":true,"acquired":false,"shares":2186,"price":29.0931,"value":63597.5166,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person prior to February 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $28.79 to $29.10, inclusive. The Reporting Person undertakes to provide to Beam Therapeutics Inc. (\"BEAM\"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":47117,"source":{"system":"sec-edgar","filing":"0000899243-23-010815","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924323010815/doc4.xml","form_type":"4"}},{"id":1925216,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-04-06T00:30:09.000Z","date":"2023-04-03","kind":"sale","planned":true,"acquired":false,"shares":2454,"price":30.31,"value":74380.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person prior to February 27, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 480 shares acquired by the Reporting Person under the Beam Therapeutics Inc. Amended and Restated 2019 Employee Stock Purchase Plan on March 31, 2023."}],"balance_after":49303,"source":{"system":"sec-edgar","filing":"0000899243-23-010815","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924323010815/doc4.xml","form_type":"4"}},{"id":1934030,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-31T23:46:33.000Z","date":"2023-01-31","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option vests in equal monthly installments each month following the date of grant for the subsequent 48 months, subject to the Reporting Person's continued service with BEAM through each vesting date."}],"balance_after":20000,"derivative":{"exercise_price":43.45,"expiration_date":"2033-01-31","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000899243-23-010132","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924323010132/doc4.xml","form_type":"4"}},{"id":1934029,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-31T23:46:33.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted to the Reporting Person under the Beam Therapeutics Inc. (\"BEAM\")  2019 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of BEAM's common stock. The RSUs vest in four substantially equal annual installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service with BEAM through each vesting date."}],"balance_after":51277,"source":{"system":"sec-edgar","filing":"0000899243-23-010132","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924323010132/doc4.xml","form_type":"4"}},{"id":2042223,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-30T21:05:17.000Z","date":"2023-01-27","kind":"exercise","acquired":false,"shares":36152,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vested as to 25% on the first anniversary of the of the vesting commencement date, August 20, 2019, and continues to vest at a rate of 2.78% each month thereafter until the option is fully vested."}],"balance_after":185565,"derivative":{"exercise_price":13.68,"expiration_date":"2029-08-31","underlying":"Common Stock","underlying_shares":36152},"source":{"system":"sec-edgar","filing":"0000899243-23-002957","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924323002957/doc4.xml","form_type":"4"}},{"id":2042222,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-30T21:05:17.000Z","date":"2023-01-26","kind":"exercise","acquired":false,"shares":1102,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vested as to 25% on the first anniversary of the of the vesting commencement date, August 20, 2019, and continues to vest at a rate of 2.78% each month thereafter until the option is fully vested."}],"balance_after":221717,"derivative":{"exercise_price":13.68,"expiration_date":"2029-08-31","underlying":"Common Stock","underlying_shares":1102},"source":{"system":"sec-edgar","filing":"0000899243-23-002957","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924323002957/doc4.xml","form_type":"4"}},{"id":2042221,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-01-30T21:05:17.000Z","date":"2023-01-27","kind":"sale","acquired":false,"shares":36152,"price":45.0804,"value":1629746.6208,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.00 to $45.24, inclusive. The Reporting Person undertakes to provide BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":31277,"source":{"system":"sec-edgar","filing":"0000899243-23-002957","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924323002957/doc4.xml","form_type":"4"}},{"id":2042220,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-01-30T21:05:17.000Z","date":"2023-01-27","kind":"exercise","acquired":true,"shares":36152,"price":13.68,"value":494559.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":67429,"source":{"system":"sec-edgar","filing":"0000899243-23-002957","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924323002957/doc4.xml","form_type":"4"}},{"id":2042219,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-01-30T21:05:17.000Z","date":"2023-01-26","kind":"sale","acquired":false,"shares":1102,"price":45.1572,"value":49763.2344,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.00 to $45.48, inclusive. The Reporting Person undertakes to provide Beam Therapeutics Inc. (\"BEAM\"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":31277,"source":{"system":"sec-edgar","filing":"0000899243-23-002957","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924323002957/doc4.xml","form_type":"4"}},{"id":2042218,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-01-30T21:05:17.000Z","date":"2023-01-26","kind":"exercise","acquired":true,"shares":1102,"price":13.68,"value":15075.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":32379,"source":{"system":"sec-edgar","filing":"0000899243-23-002957","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924323002957/doc4.xml","form_type":"4"}},{"id":2046445,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-25T22:25:17.000Z","date":"2023-01-24","kind":"exercise","acquired":false,"shares":14810,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vested as to 25% on the first anniversary of the of the vesting commencement date, August 20, 2019, and continues to vest at a rate of 2.78% each month thereafter until the option is fully vested."}],"balance_after":222819,"derivative":{"exercise_price":13.68,"expiration_date":"2029-08-31","underlying":"Common Stock","underlying_shares":14810},"source":{"system":"sec-edgar","filing":"0000899243-23-002666","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924323002666/doc4.xml","form_type":"4"}},{"id":2046444,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-25T22:25:17.000Z","date":"2023-01-23","kind":"exercise","acquired":false,"shares":5426,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vested as to 25% on the first anniversary of the of the vesting commencement date, August 20, 2019, and continues to vest at a rate of 2.78% each month thereafter until the option is fully vested."}],"balance_after":237629,"derivative":{"exercise_price":13.68,"expiration_date":"2029-08-31","underlying":"Common Stock","underlying_shares":5426},"source":{"system":"sec-edgar","filing":"0000899243-23-002666","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924323002666/doc4.xml","form_type":"4"}},{"id":2046443,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-01-25T22:25:17.000Z","date":"2023-01-24","kind":"sale","acquired":false,"shares":14810,"price":45.014,"value":666657.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.00 to $45.10, inclusive. The Reporting Person undertakes to provide BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":31277,"source":{"system":"sec-edgar","filing":"0000899243-23-002666","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924323002666/doc4.xml","form_type":"4"}},{"id":2046442,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-01-25T22:25:17.000Z","date":"2023-01-24","kind":"exercise","acquired":true,"shares":14810,"price":13.68,"value":202600.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":46087,"source":{"system":"sec-edgar","filing":"0000899243-23-002666","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924323002666/doc4.xml","form_type":"4"}},{"id":2046441,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-01-25T22:25:17.000Z","date":"2023-01-23","kind":"sale","acquired":false,"shares":5426,"price":45.0221,"value":244289.9146,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.00 to $45.18, inclusive. The Reporting Person undertakes to provide Beam Therapeutics Inc. (\"BEAM\"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":31277,"source":{"system":"sec-edgar","filing":"0000899243-23-002666","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924323002666/doc4.xml","form_type":"4"}},{"id":2046440,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-01-25T22:25:17.000Z","date":"2023-01-23","kind":"exercise","acquired":true,"shares":5426,"price":13.68,"value":74227.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":36703,"source":{"system":"sec-edgar","filing":"0000899243-23-002666","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924323002666/doc4.xml","form_type":"4"}},{"id":2049790,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-20T21:18:22.000Z","date":"2023-01-18","kind":"exercise","acquired":false,"shares":39886,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vested as to 25% on the first anniversary of the of the vesting commencement date, August 20, 2019, and continues to vest at a rate of 2.78% each month thereafter until the option is fully vested."}],"balance_after":243055,"derivative":{"exercise_price":13.68,"expiration_date":"2029-08-31","underlying":"Common Stock","underlying_shares":39886},"source":{"system":"sec-edgar","filing":"0000899243-23-002260","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924323002260/doc4.xml","form_type":"4"}},{"id":2049789,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-01-20T21:18:22.000Z","date":"2023-01-18","kind":"sale","acquired":false,"shares":47195,"price":45.14,"value":2130382.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.00 to $45.50, inclusive. The Reporting Person undertakes to provide BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 308 shares acquired by the Reporting Person under the Beam Therapeutics Inc. (\"BEAM\") Amended and Restated 2019 Employee Stock Purchase Plan on September 30, 2022."}],"balance_after":31277,"source":{"system":"sec-edgar","filing":"0000899243-23-002260","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924323002260/doc4.xml","form_type":"4"}},{"id":2049788,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-01-20T21:18:22.000Z","date":"2023-01-18","kind":"exercise","acquired":true,"shares":39886,"price":13.68,"value":545640.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 308 shares acquired by the Reporting Person under the Beam Therapeutics Inc. (\"BEAM\") Amended and Restated 2019 Employee Stock Purchase Plan on September 30, 2022."}],"balance_after":78472,"source":{"system":"sec-edgar","filing":"0000899243-23-002260","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924323002260/doc4.xml","form_type":"4"}},{"id":2061702,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2023-01-05T23:24:29.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":1821,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were issued pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":159235,"source":{"system":"sec-edgar","filing":"0001209191-23-002059","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123002059/doc4.xml","form_type":"4"}},{"id":2141870,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-10-06T01:12:18.000Z","date":"2022-10-03","kind":"grant","acquired":true,"shares":1265,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were issued pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":157414,"source":{"system":"sec-edgar","filing":"0001209191-22-052911","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122052911/doc4.xml","form_type":"4"}},{"id":2211333,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-07-06T21:48:29.000Z","date":"2022-07-01","kind":"grant","acquired":true,"shares":1631,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were issued pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":156149,"source":{"system":"sec-edgar","filing":"0001209191-22-041276","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122041276/doc4.xml","form_type":"4"}},{"id":2229481,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-17T00:12:50.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":36290,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":36290,"derivative":{"exercise_price":6.2,"exercise_date":"2023-06-14","expiration_date":"2032-06-14","underlying":"Class A Common Stock","underlying_shares":36290},"source":{"system":"sec-edgar","filing":"0001209191-22-037631","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122037631/doc4.xml","form_type":"4"}},{"id":2229480,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-06-17T00:12:50.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":18145,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units automatically granted pursuant to the Issuer's Outside Director Compensation Policy.  The restricted stock units will vest on the earlier of June 14, 2023 or the day prior to the Issuer's 2023 annual meeting of stockholders."}],"balance_after":154518,"source":{"system":"sec-edgar","filing":"0001209191-22-037631","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122037631/doc4.xml","form_type":"4"}},{"id":2303474,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-04-05T23:23:51.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":1788,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were issued pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":136373,"source":{"system":"sec-edgar","filing":"0001209191-22-023316","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122023316/doc4.xml","form_type":"4"}},{"id":2308469,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2022-04-05T00:22:01.000Z","date":"2022-03-31","kind":"sale","acquired":false,"shares":1787,"price":59.11,"value":105629.57,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These shares of common stock were automatically sold in a non-discretionary transaction by the Reporting Person in order to cover tax withholding obligations upon the vesting of certain RSUs."}],"balance_after":38278,"source":{"system":"sec-edgar","filing":"0000899243-22-013485","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924322013485/doc4.xml","form_type":"4"}},{"id":2308468,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2022-04-05T00:22:01.000Z","date":"2022-03-31","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted to the Reporting Person under the Issuer's 2019 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs vest in four substantially equal annual installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service with the Company through each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 256 shares acquired under the Issuer's employee stock purchase plan on March 31, 2022."}],"balance_after":40065,"source":{"system":"sec-edgar","filing":"0000899243-22-013485","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924322013485/doc4.xml","form_type":"4"}},{"id":2416965,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-02T23:00:12.000Z","date":"2022-01-31","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in equal monthly installments each month following the date of grant for the subsequent 48 months, subject to the reporting person's continued service with Beam Therapeutics Inc. through each vesting date.\nNote: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.\nPotential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number."}],"balance_after":30000,"derivative":{"exercise_price":69.21,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000899243-22-004196","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924322004196/doc4.xml","form_type":"4"}},{"id":2442783,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-01-06T01:41:41.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":763,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were issued pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":134585,"source":{"system":"sec-edgar","filing":"0001209191-22-002050","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919122002050/doc4.xml","form_type":"4"}},{"id":2547967,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-10-06T00:33:34.000Z","date":"2021-10-01","kind":"grant","acquired":true,"shares":629,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were issued pursuant to the Issuer's Outside Director Compensation Policy."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":133822,"source":{"system":"sec-edgar","filing":"0001209191-21-059745","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919121059745/doc4.xml","form_type":"4"}},{"id":2640469,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-07-06T21:00:27.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":382,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were issued pursuant to the Issuer's Outside Director Compensation Policy."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":133193,"source":{"system":"sec-edgar","filing":"0001209191-21-045551","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919121045551/doc4.xml","form_type":"4"}},{"id":2645043,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-02T22:01:02.000Z","date":"2021-06-30","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercise reported in this Form 4 was effected pursuant to a 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests as to 25% on the first anniversary of the of the vesting commencement date, August 20, 2019, and at a rate of 2.78% each month thereafter until the option is fully vested."}],"balance_after":282941,"derivative":{"exercise_price":13.68,"expiration_date":"2029-08-31","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000899243-21-027313","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924321027313/doc4.xml","form_type":"4"}},{"id":2645042,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2021-07-02T22:01:02.000Z","date":"2021-06-30","kind":"sale","acquired":false,"shares":15000,"price":127,"value":1905000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4  were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":24809,"source":{"system":"sec-edgar","filing":"0000899243-21-027313","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924321027313/doc4.xml","form_type":"4"}},{"id":2645041,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2021-07-02T22:01:02.000Z","date":"2021-06-30","kind":"sale","acquired":false,"shares":15000,"price":117,"value":1755000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4  were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":39809,"source":{"system":"sec-edgar","filing":"0000899243-21-027313","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924321027313/doc4.xml","form_type":"4"}},{"id":2645040,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2021-07-02T22:01:02.000Z","date":"2021-06-30","kind":"exercise","acquired":true,"shares":30000,"price":13.68,"value":410400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercise reported in this Form 4 was effected pursuant to a 10b5-1 trading plan."}],"balance_after":54809,"source":{"system":"sec-edgar","filing":"0000899243-21-027313","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924321027313/doc4.xml","form_type":"4"}},{"id":2650228,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-30T22:00:23.000Z","date":"2021-06-28","kind":"exercise","acquired":false,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercise reported in this Form 4 was effected pursuant to a 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The option vests as to 25% on the first anniversary of the of the vesting commencement date, August 20, 2019, and at a rate of 2.78% each month thereafter until the option is fully vested."}],"balance_after":312941,"derivative":{"exercise_price":13.68,"expiration_date":"2029-08-31","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0000899243-21-026779","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924321026779/doc4.xml","form_type":"4"}},{"id":2650227,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2021-06-30T22:00:23.000Z","date":"2021-06-28","kind":"sale","acquired":false,"shares":19800,"price":109.41,"value":2166318.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4  were effected pursuant to a Rule 10b5-1 trading plan. Each sale price reported is a weighted average price. The Reporting Person undertakes to provide to Beam Therapeutics Inc. (\"BEAM\"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.00 to $109.98, inclusive."}],"balance_after":24809,"source":{"system":"sec-edgar","filing":"0000899243-21-026779","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924321026779/doc4.xml","form_type":"4"}},{"id":2650226,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2021-06-30T22:00:23.000Z","date":"2021-06-28","kind":"sale","acquired":false,"shares":4803,"price":108.45,"value":520885.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4  were effected pursuant to a Rule 10b5-1 trading plan. Each sale price reported is a weighted average price. The Reporting Person undertakes to provide to Beam Therapeutics Inc. (\"BEAM\"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.00 to $108.99, inclusive."}],"balance_after":44609,"source":{"system":"sec-edgar","filing":"0000899243-21-026779","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924321026779/doc4.xml","form_type":"4"}},{"id":2650225,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2021-06-30T22:00:23.000Z","date":"2021-06-28","kind":"sale","acquired":false,"shares":3290,"price":107.2,"value":352688.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4  were effected pursuant to a Rule 10b5-1 trading plan. Each sale price reported is a weighted average price. The Reporting Person undertakes to provide to Beam Therapeutics Inc. (\"BEAM\"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.00 to $107.90, inclusive."}],"balance_after":49412,"source":{"system":"sec-edgar","filing":"0000899243-21-026779","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924321026779/doc4.xml","form_type":"4"}},{"id":2650224,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2021-06-30T22:00:23.000Z","date":"2021-06-28","kind":"sale","acquired":false,"shares":8907,"price":106.13,"value":945299.91,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4  were effected pursuant to a Rule 10b5-1 trading plan. Each sale price reported is a weighted average price. The Reporting Person undertakes to provide to Beam Therapeutics Inc. (\"BEAM\"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.00 to $106.89, inclusive."}],"balance_after":52702,"source":{"system":"sec-edgar","filing":"0000899243-21-026779","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924321026779/doc4.xml","form_type":"4"}},{"id":2650223,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2021-06-30T22:00:23.000Z","date":"2021-06-28","kind":"sale","acquired":false,"shares":5220,"price":105.34,"value":549874.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4  were effected pursuant to a Rule 10b5-1 trading plan. Each sale price reported is a weighted average price. The Reporting Person undertakes to provide to Beam Therapeutics Inc. (\"BEAM\"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.00 to $105.95, inclusive."}],"balance_after":61609,"source":{"system":"sec-edgar","filing":"0000899243-21-026779","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924321026779/doc4.xml","form_type":"4"}},{"id":2650222,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2021-06-30T22:00:23.000Z","date":"2021-06-28","kind":"sale","acquired":false,"shares":1880,"price":104.63,"value":196704.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4  were effected pursuant to a Rule 10b5-1 trading plan. Each sale price reported is a weighted average price. The Reporting Person undertakes to provide to Beam Therapeutics Inc. (\"BEAM\"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.58 to $104.96, inclusive."}],"balance_after":66829,"source":{"system":"sec-edgar","filing":"0000899243-21-026779","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924321026779/doc4.xml","form_type":"4"}},{"id":2650221,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2021-06-30T22:00:23.000Z","date":"2021-06-28","kind":"sale","acquired":false,"shares":1100,"price":103.86,"value":114246.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4  were effected pursuant to a Rule 10b5-1 trading plan. Each sale price reported is a weighted average price. The Reporting Person undertakes to provide to Beam Therapeutics Inc. (\"BEAM\"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.74 to $103.97, inclusive."}],"balance_after":68709,"source":{"system":"sec-edgar","filing":"0000899243-21-026779","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924321026779/doc4.xml","form_type":"4"}},{"id":2650220,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2021-06-30T22:00:23.000Z","date":"2021-06-28","kind":"exercise","acquired":true,"shares":45000,"price":13.68,"value":615600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercise reported in this Form 4 was effected pursuant to a 10b5-1 trading plan."}],"balance_after":69809,"source":{"system":"sec-edgar","filing":"0000899243-21-026779","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924321026779/doc4.xml","form_type":"4"}},{"id":2741558,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-22T23:38:04.000Z","date":"2021-04-20","kind":"exercise","acquired":true,"shares":404688,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One forty-eighth (1/48th) of the shares subject to the award shall vest one month after April 29, 2020, or the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, each share of Common Stock shall be reclassified into one share of Class A Common Stock."}],"balance_after":404688,"derivative":{"exercise_price":2.22,"expiration_date":"2030-04-28","underlying":"Class A Common","underlying_shares":404688},"source":{"system":"sec-edgar","filing":"0001209191-21-028020","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919121028020/doc4.xml","form_type":"4"}},{"id":2741557,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-22T23:38:04.000Z","date":"2021-04-20","kind":"exercise","acquired":false,"shares":404688,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One forty-eighth (1/48th) of the shares subject to the award shall vest one month after April 29, 2020, or the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, each share of Common Stock shall be reclassified into one share of Class A Common Stock."}],"balance_after":0,"derivative":{"exercise_price":2.22,"expiration_date":"2030-04-28","underlying":"Common Stock","underlying_shares":404688},"source":{"system":"sec-edgar","filing":"0001209191-21-028020","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919121028020/doc4.xml","form_type":"4"}},{"id":2741556,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-22T23:38:04.000Z","date":"2021-04-20","kind":"exercise","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option becomes exercisable upon the earlier of April 15, 2022 or the date of the Issuer's first annual meeting of stockholders."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, each share of Common Stock shall be reclassified into one share of Class A Common Stock."}],"balance_after":12500,"derivative":{"exercise_price":18,"expiration_date":"2031-04-14","underlying":"Class A Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-21-028020","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919121028020/doc4.xml","form_type":"4"}},{"id":2741555,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-22T23:38:04.000Z","date":"2021-04-20","kind":"exercise","acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option becomes exercisable upon the earlier of April 15, 2022 or the date of the Issuer's first annual meeting of stockholders."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, each share of Common Stock shall be reclassified into one share of Class A Common Stock."}],"balance_after":0,"derivative":{"exercise_price":18,"expiration_date":"2031-04-14","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-21-028020","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919121028020/doc4.xml","form_type":"4"}},{"id":2741554,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-04-22T23:38:04.000Z","date":"2021-04-20","kind":"exercise","acquired":true,"shares":6250,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The shares are represented by restricted stock units (\"RSUs\"). Each RSU represents the Reporting Person's right to receive one share of common stock of the Issuer, with all such shares being received on the earlier of April 16, 2022 or the Issuer's first annual meeting of stockholders."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, each share of Common Stock shall be reclassified into one share of Class A Common Stock."}],"balance_after":132811,"source":{"system":"sec-edgar","filing":"0001209191-21-028020","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919121028020/doc4.xml","form_type":"4"}},{"id":2741553,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-22T23:38:04.000Z","date":"2021-04-20","kind":"exercise","acquired":false,"shares":6250,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The shares are represented by restricted stock units (\"RSUs\"). Each RSU represents the Reporting Person's right to receive one share of common stock of the Issuer, with all such shares being received on the earlier of April 16, 2022 or the Issuer's first annual meeting of stockholders."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, each share of Common Stock shall be reclassified into one share of Class A Common Stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-028020","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919121028020/doc4.xml","form_type":"4"}},{"id":2741552,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-04-22T23:38:04.000Z","date":"2021-04-20","kind":"other","acquired":true,"shares":126561,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, each share of Common Stock shall be reclassified into one share of Class A Common Stock."}],"balance_after":126561,"source":{"system":"sec-edgar","filing":"0001209191-21-028020","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919121028020/doc4.xml","form_type":"4"}},{"id":2741551,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-22T23:38:04.000Z","date":"2021-04-20","kind":"other","acquired":false,"shares":126561,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, each share of Common Stock shall be reclassified into one share of Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, each share of Common Stock shall be reclassified into one share of Class A Common Stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-028020","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919121028020/doc4.xml","form_type":"4"}},{"id":2744711,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-19T23:23:52.000Z","date":"2021-04-15","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option becomes exercisable upon the earlier of April 15, 2022 or the date of the Issuer's first annual meeting of stockholders."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, each share of Common Stock shall be reclassified into one share of Class A Common Stock."}],"balance_after":12500,"derivative":{"exercise_price":18,"expiration_date":"2031-04-14","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-21-027394","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919121027394/doc4.xml","form_type":"4"}},{"id":2744710,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-19T23:23:52.000Z","date":"2021-04-16","kind":"grant","acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, each share of Common Stock shall be reclassified into one share of Class A Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares are represented by restricted stock units (\"RSUs\"). Each RSU represents the Reporting Person's right to receive one share of common stock of the Issuer, with all such shares being received on the earlier of April 16, 2022 or the Issuer's first annual meeting of stockholders."}],"balance_after":126561,"source":{"system":"sec-edgar","filing":"0001209191-21-027394","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919121027394/doc4.xml","form_type":"4"}},{"id":2761527,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-02T21:11:25.000Z","date":"2021-03-31","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests in equal monthly installments each month following the date of grant for the subsequent 48 months, subject to the Reporting Person's continued service with the Company through each vesting date."}],"balance_after":35000,"derivative":{"exercise_price":80.04,"expiration_date":"2031-03-31","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0000899243-21-014610","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924321014610/doc4.xml","form_type":"4"}},{"id":2761526,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2021-04-02T21:11:25.000Z","date":"2021-03-31","kind":"grant","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted to the Reporting Person under the Company's 2019 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in four substantially equal annual installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service with the Company through each vesting date."}],"balance_after":24809,"source":{"system":"sec-edgar","filing":"0000899243-21-014610","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924321014610/doc4.xml","form_type":"4"}},{"id":2921136,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-05T22:40:46.000Z","date":"2021-01-04","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Each price reported for transactions affected pursuant to the Rule 10b5-1 trading plan is a weighted average price. The Reporting Person undertakes to provide to BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the stock option vested on the first anniversary of the of the vesting commencement date, August 20, 2019, and the remaining shares shall vest in 36 substantially equal monthly installments thereafter, subject to continued service with BEAM through such dates."}],"balance_after":357941,"derivative":{"exercise_price":13.68,"expiration_date":"2029-08-31","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000899243-21-000430","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924321000430/doc4.xml","form_type":"4"}},{"id":2921135,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2021-01-05T22:40:46.000Z","date":"2021-01-04","kind":"sale","acquired":false,"shares":900,"price":83.89,"value":75501.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Each price reported for transactions affected pursuant to the Rule 10b5-1 trading plan is a weighted average price. The Reporting Person undertakes to provide to BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"These shares were sold in multiple transactions ranging from $83.85 to $84.01 inclusive."}],"balance_after":7309,"source":{"system":"sec-edgar","filing":"0000899243-21-000430","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924321000430/doc4.xml","form_type":"4"}},{"id":2921134,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2021-01-05T22:40:46.000Z","date":"2021-01-04","kind":"sale","acquired":false,"shares":7095,"price":83.15,"value":589949.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Each price reported for transactions affected pursuant to the Rule 10b5-1 trading plan is a weighted average price. The Reporting Person undertakes to provide to BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"These shares were sold in multiple transactions ranging from $82.80 to $83.78 inclusive."}],"balance_after":8209,"source":{"system":"sec-edgar","filing":"0000899243-21-000430","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924321000430/doc4.xml","form_type":"4"}},{"id":2921133,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2021-01-05T22:40:46.000Z","date":"2021-01-04","kind":"sale","acquired":false,"shares":5296,"price":82.44,"value":436602.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Each price reported for transactions affected pursuant to the Rule 10b5-1 trading plan is a weighted average price. The Reporting Person undertakes to provide to BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"These shares were sold in multiple transactions ranging from $81.80 to $82.79 inclusive."}],"balance_after":15304,"source":{"system":"sec-edgar","filing":"0000899243-21-000430","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924321000430/doc4.xml","form_type":"4"}},{"id":2921132,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2021-01-05T22:40:46.000Z","date":"2021-01-04","kind":"sale","acquired":false,"shares":6509,"price":81.26,"value":528921.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Each price reported for transactions affected pursuant to the Rule 10b5-1 trading plan is a weighted average price. The Reporting Person undertakes to provide to BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"These shares were sold in multiple transactions ranging from $80.73 to $81.72 inclusive."}],"balance_after":20600,"source":{"system":"sec-edgar","filing":"0000899243-21-000430","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924321000430/doc4.xml","form_type":"4"}},{"id":2921131,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2021-01-05T22:40:46.000Z","date":"2021-01-04","kind":"sale","acquired":false,"shares":2449,"price":80.25,"value":196532.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Each price reported for transactions affected pursuant to the Rule 10b5-1 trading plan is a weighted average price. The Reporting Person undertakes to provide to BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"These shares were sold in multiple transactions ranging from $79.73 to $80.72 inclusive."}],"balance_after":27109,"source":{"system":"sec-edgar","filing":"0000899243-21-000430","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924321000430/doc4.xml","form_type":"4"}},{"id":2921130,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2021-01-05T22:40:46.000Z","date":"2021-01-04","kind":"sale","acquired":false,"shares":1951,"price":79.21,"value":154538.71,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Each price reported for transactions affected pursuant to the Rule 10b5-1 trading plan is a weighted average price. The Reporting Person undertakes to provide to BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"These shares were sold in multiple transactions ranging from $78.72 to $79.65 inclusive."}],"balance_after":29558,"source":{"system":"sec-edgar","filing":"0000899243-21-000430","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924321000430/doc4.xml","form_type":"4"}},{"id":2921129,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2021-01-05T22:40:46.000Z","date":"2021-01-04","kind":"sale","acquired":false,"shares":800,"price":78.05,"value":62440.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Each price reported for transactions affected pursuant to the Rule 10b5-1 trading plan is a weighted average price. The Reporting Person undertakes to provide to BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These shares were sold in multiple transactions ranging from $77.65 to $78.48 inclusive."}],"balance_after":31509,"source":{"system":"sec-edgar","filing":"0000899243-21-000430","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924321000430/doc4.xml","form_type":"4"}},{"id":2921128,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2021-01-05T22:40:46.000Z","date":"2021-01-04","kind":"exercise","acquired":true,"shares":25000,"price":13.68,"value":342000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Each price reported for transactions affected pursuant to the Rule 10b5-1 trading plan is a weighted average price. The Reporting Person undertakes to provide to BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":32309,"source":{"system":"sec-edgar","filing":"0000899243-21-000430","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924321000430/doc4.xml","form_type":"4"}},{"id":3026114,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-09-22T01:08:54.000Z","date":"2020-09-18","kind":"exercise","acquired":false,"shares":7309,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the stock option shall vest on the first anniversary of the of the vesting commencement date, August 20, 2019, and the remaining shares shall vest in 36 substantially equal monthly installments thereafter, subject to continued service with BEAM through such dates."}],"balance_after":382941,"derivative":{"exercise_price":13.68,"expiration_date":"2029-08-31","underlying":"Common Stock","underlying_shares":7309},"source":{"system":"sec-edgar","filing":"0000899243-20-025849","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924320025849/doc4.xml","form_type":"4"}},{"id":3026113,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":89177,"kind":"person","name":"Burrell Terry-Ann","position":1,"cik":"0001786484","reported_name":"Burrell Terry-Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2020-09-22T01:08:54.000Z","date":"2020-09-18","kind":"exercise","acquired":true,"shares":7309,"price":13.68,"value":99987.12,"ownership":{"direct":true},"balance_after":7309,"source":{"system":"sec-edgar","filing":"0000899243-20-025849","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000089924320025849/doc4.xml","form_type":"4"}}]}